Literature DB >> 5424294

Autopsy study of adrenals in unselected normotensive and hypertensive patients.

P Granger, J Genest.   

Abstract

The records of the Hôtel-Dieu Hospital of Montreal, a general teaching hospital, provided 2425 consecutive autopsies done between January 1, 1955 and January 1, 1965. According to the diagnostic criteria used, 44.2% of the patients were hypertensive. Adrenal adenomas, nodules or hyperplasia were found in 7% of the hypertensive patients and in only 1.9% of the normotensive ones. The most frequently encountered lesion was adenoma (4.2% in the hypertensive population and 1.1% in the normotensive one). These results constitute supportive evidence for a low incidence of "normokalemic primary aldosteronism".

Entities:  

Mesh:

Year:  1970        PMID: 5424294      PMCID: PMC1930349     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  A study of the adrenal status in hypertension.

Authors:  A H SHAMMA; J W GODDARD; S C SOMMERS
Journal:  J Chronic Dis       Date:  1958-11

3.  Adrenal adenoma and hypertension.

Authors:  J P Kokko; T C Brown; M M Berman
Journal:  Lancet       Date:  1967-03-04       Impact factor: 79.321

4.  Preoperative diagnosis of primary aldosteronism, including a comparison of operative findings and preoperative tumor localization by adrenal phlebography.

Authors:  J W Conn; D R Rovner; E L Cohen; J J Bookstein; J C Cerny; C P Lucas
Journal:  Arch Intern Med       Date:  1969-02

5.  Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism.

Authors:  N M Kaplan
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

6.  Effect of diazoxide on plasma renin activity in hypertensive patients.

Authors:  O Küchel; L M Fishman; G W Liddle; A Michelakis
Journal:  Ann Intern Med       Date:  1967-10       Impact factor: 25.391

7.  Plasma renin activity in healthy subjects and patients with hypertension. Preliminary experience with a rapid and quantitative bio-assay.

Authors:  J C Gunnells; C E Grim; R R Robinson; N M Wildermann
Journal:  Arch Intern Med       Date:  1967-03
  7 in total
  8 in total

Review 1.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

2.  Release of corticosteroids from human adrenals in vitro.

Authors:  B Hamberger; T Curstedt; S Werner
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

3.  Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Authors:  S Bovio; A Cataldi; G Reimondo; P Sperone; S Novello; A Berruti; P Borasio; C Fava; L Dogliotti; G V Scagliotti; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

4.  Abnormalities in incidentally removed adrenal glands.

Authors:  H Buurman; W Saeger
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  Hyperplastic and Tumorous Lesions of the Adrenals in an Unselected Autopsy Series.

Authors:  Wolfgang Saeger; Karin Reinhard; Christina Reinhard
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

6.  Coexistence of pheochromocytoma, adrenal adenoma and hypokalemia.

Authors:  G E Wilkins; N Schmidt; L Lee-Son
Journal:  Can Med Assoc J       Date:  1977-02-19       Impact factor: 8.262

7.  Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.

Authors:  J Waldmann; D K Bartsch; P H Kann; V Fendrich; M Rothmund; P Langer
Journal:  Langenbecks Arch Surg       Date:  2007-01-19       Impact factor: 2.895

Review 8.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.